Screener
Immunome IMNM Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Immunome’s reported figures.
Based on the most recent quarter.
The source filing: Immunome’s 10-Q, filed May 12, 2026. Open the filing →
- Filed
- May 12, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219425
FAQ
- What is Immunome's current ratio?
- Immunome (IMNM) reported current ratio of 21.7× in Q1 2026.
- How has Immunome's current ratio changed year-over-year?
- Immunome's current ratio increased by 106.6% year-over-year, from 10.5× to 21.7×.
- What is the long-term trend for Immunome's current ratio?
- Over 5 years (2020 to 2025), Immunome's current ratio has grown at a 0.8% compound annual growth rate (CAGR), from 14.1× to 14.7×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Immunome's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude